Mark T. Schneider, MD MPH

Medical Affairs & Clinical Development

San Francisco Bay Area

About

Dr. Schneider’s experience combines a unique blend of both military and medical expertise with a longstanding dedication to the development of clinically focused healthcare solutions. He has been involved in a myriad of activities throughout his career that have both influenced and provided him with strong strategic leadership qualities required for life science and biotechnology. Dr. Schneider understands the business of both biotech and the pharmaceutical industry. He possesses deep domain expertise in healthcare policy and public health. He has been a part of product launches both in the EU and US on both the medical affairs and clinical development side of the house. Subject Matter Expertise : Surgery, Pain Management, Immunology, Biosimilars, Nephrology, Cardiovascular, Metabolic, Hematology, Oncology, Neurology and Respiratory

Experience

  • Medical Director Clinical Developmemt at Ascendis Pharma
    Jan 2023 - Present · 3 yrs 6 mos

  • President and Owner at P.O.M.A.L Inc.
    May 2022 - Present · 4 yrs 2 mos

    BioPharma Strategic Advisors and Partnerships

  • Senior Director Clinical Development and Medical Affairs at Quince Therapeutics
    Jul 2022 - Jan 2023 · 7 mos

  • Sr. Director, Global Medical Affairs - Infectious Disease at Emergent BioSolutions
    Jan 2020 - Jul 2022 · 2 yrs 7 mos

  • Director of Medical Affairs, Account Medical Advisors EAST at Boehringer Ingelheim
    Aug 2018 - Jan 2020 · 1 yr 6 mos